Tag Archives: agenda

RESI Boston 2016 Agenda Announced

1 Sep

By Michael Quigley, VP of Market Research, LSN

mike-2

LSN’s, Redefining Early Stage Investments conference series, is back in Boston for its 10th conference. The RESI team has produced a content rich agenda featuring over 75 investors on 18 different panels, and 5 educational workshop sessions. Investors from family offices, top tier VC’s, large pharma/medical technology firms, angels will be shedding light regarding their process of making investment decisions and what early stage companies should be doing to stand out from the crowd.

RESI Boston also represents an amazing geographic diversity with investors hailing from North America, Europe and Asia all with a common goal of sourcing early stage assets. There will be a new Asia-North America Investor Track that will feature a total of 15 different speakers representing Japan, Korea and China based firms looking to make investments across the pacific. The broad strategy of these Asian based investors is simple – identify compelling assets for their dynamic markets.

The agenda below represents the current early-stage healthcare investment landscape and how it has adapted to serve this evolving industry. Click on any image below to see the full speaker lineup for yourself and to decide who you will be listening to come September 13th.

Track 1: Therapeutics Investor Panels Track 2: Device, Diagnostic, and HCIT Investor Panels Track 3: Early Stage Workshops
Track 1: Therapeutics Investor Panels Track 2: Device, Diagnostic, and HCIT Investor Panels Track 4: Asia-North America Panels

Tags: , , ,

RESI on MaRS Agenda Announced

28 Apr

By Nono Hu, Director of Marketing, LSN

With less than 60 days to go before launch, LSN is announcing the content agenda for RESI on MaRS. With three tracks of panel and workshop content, RESI will feature a wealth of speakers representing many different types of life science investors, including family offices, angels, venture philanthropy, major pharma and medical device corporations, and more.

It’s the first RESI event outside the US, and we’re looking forward to this opportunity to share all that Toronto’s healthcare innovation hub has to offer with investors and innovators from beyond Canada’s borders. Look out for speaker announcements in forthcoming editions of Next Phase.

wp

Tags: , , ,

RESI@TMCx: Agenda Announced

11 Feb

By Nono Hu, Director of Marketing, LSN

RESI is returning to TMCx on April 11th, and LSN has scheduled two all-day tracks of panel sessions that illuminate every corner of the life science investment landscape. Panels will feature senior, experienced investors from a diversity of investor types – including family offices, VCs, angel syndicates, major global pharma and medical device firms, and more. These investors will explore new investment trends in their sectors, and will share their knowledge and insights with RESI’s audience of entrepreneurs. If you’d like to join us at RESI@TMCx to hear the latest on life science financing and book one-on-one meetings with investors, you can register here.

Tags: , , ,

Newer Entries →